Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.73
-0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Voyager Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
80M 250.01M 40.91M 37.41M
Cost of Revenue
n/a 4.44M 6.19M 73.79M
Gross Profit
80M 245.57M 34.72M -36.37M
Operating Income
-83.29M 122.01M -50.84M -73.62M
Interest Income
n/a 11.72M 1.79M 390K
Pretax Income
-64.34M 133.74M -46.39M -71.2M
Net Income
-65M 132.33M -46.41M -66.03M
Selling & General & Admin
35.92M 35.82M 30.98M 37.25M
Research & Development
127.37M 92.17M 60.76M 73.79M
Other Expenses
n/a n/a 4.45M 2.42M
Operating Expenses
163.29M 127.99M 91.74M 111.03M
Interest Expense
n/a n/a 1.79M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
163.29M 127.99M 91.74M 111.03M
Income Tax Expense
665K 1.41M 16K -5.17M
Shares Outstanding (Basic)
57.67M 43.02M 38.36M 37.67M
Shares Outstanding (Diluted)
57.67M 44.57M 38.36M 37.67M
EPS (Basic)
-1.13 3.08 -1.21 -1.75
EPS (Diluted)
-1.13 2.97 -1.21 -1.75
EBITDA
-78.56M 126.45M -44.65M -68.45M
EBIT
-83.29M 122.01M -50.84M -73.62M
Depreciation & Amortization
4.73M 4.44M 6.19M 5.17M